We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.36B
AUM Growth
-$521M
Cap. Flow
-$561M
Cap. Flow %
-16.68%
Top 10 Hldgs %
31.32%
Holding
2,193
New
694
Increased
377
Reduced
430
Closed
579

Top Buys

Rank Stock Value
1
KAHC
KKR Acquisition Holdings I Corp.
KAHC
+$36.2M
2
PRAH
PRA Health Sciences, Inc.
PRAH
+$19.4M
3
PFPT
Proofpoint, Inc.
PFPT
+$17.4M
4
NUAN
Nuance Communications, Inc.
NUAN
+$15.4M
5
INFO
IHS Markit Ltd. Common Shares
INFO
+$15.2M

Top Sells

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$39.4M
2
KAHC.U
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
+$37M
3
RP
RealPage, Inc.
RP
+$15.7M
4
HMSY
HMS Holdings Corp.
HMSY
+$14.5M
5
VAR
Varian Medical Systems, Inc.
VAR
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 8.97%
2 Financials 8.87%
3 Consumer Discretionary 6.82%
4 Industrials 6.08%
5 Healthcare 5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLGN
1451
DELISTED
Heliogen, Inc.
HLGN
$97K ﹤0.01%
+286
New +$97.2K
CRZN
1452
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
$97K ﹤0.01%
+10,000
New +$97.2K
TBSA
1453
DELISTED
TB SA Acquisition Corp Class A Ordinary Share
TBSA
$97K ﹤0.01%
+10,000
New +$97K
ESM
1454
DELISTED
ESM Acquisition Corporation
ESM
$97K ﹤0.01%
+10,000
New +$97.3K
EBAC
1455
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$97K ﹤0.01%
+10,000
New +$98.2K
IBER
1456
DELISTED
Ibere Pharmaceuticals
IBER
$97K ﹤0.01%
+10,000
New +$97.3K
TSPQ
1457
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
$97K ﹤0.01%
+10,000
New +$97.2K
CRU
1458
DELISTED
Crucible Acquisition Corporation
CRU
$97K ﹤0.01%
+10,000
New +$98.1K
SBII
1459
DELISTED
Sandbridge X2 Corp.
SBII
$97K ﹤0.01%
+10,000
New +$97.7K
SBEA
1460
DELISTED
SilverBox Engaged Merger Corp I Class A Common Stock
SBEA
$97K ﹤0.01%
+10,000
New +$97.8K
GLHA
1461
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
$96K ﹤0.01%
+10,000
New +$96.6K
FAZEW
1462
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$95K ﹤0.01%
+79,393
New +$80.5K
PRVB
1463
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$95K ﹤0.01%
+11,300
New +$91.2K
LHC.WS
1464
DELISTED
Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
LHC.WS
$94K ﹤0.01%
+96,435
New +$76.6K
SIOX
1465
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$93K ﹤0.01%
34,000
– –
SHACW
1466
DELISTED
SCP & CO Healthcare Acquisition Company Warrant
SHACW
$92K ﹤0.01%
+108,225
New +$69.2K
MDH.WS
1467
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$91K ﹤0.01%
110,125
+9,625
+10% +$5.82K
TELL
1468
CALL
DELISTED
Tellurian Inc.
TELL
$89K ﹤0.01%
19,100
-500
-3% -$1.53K
AGIG
1469
Abundia Global Impact Group
AGIG
$36.5M
$85K ﹤0.01%
+3,408
New +$58.5K
QTTB icon
1470
Q32 Bio
QTTB
$464M
$84K ﹤0.01%
+644
New +$80.4K
GSAT icon
1471
CALL
Globalstar
GSAT
$10.8B
$82K ﹤0.01%
3,067
+720
+31% +$14.1K
IDEX
1472
CALL
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$82K ﹤0.01%
230
-191
-45% -$68.2K
XWEL icon
1473
CALL
XWELL
XWEL
$8.61M
$80K ﹤0.01%
2,600
-625
-19% -$17.8K
ATOS icon
1474
CALL
Atossa Therapeutics
ATOS
$23.5M
$78K ﹤0.01%
827
-280
-25% -$14.8K
JNCE
1475
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$78K ﹤0.01%
+11,400
New +$94.7K
57 58
59
60 61

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Prelude Capital Management held 2,193 positions worth $3.36B, down 13% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Prelude Capital Management withdrew a net $561M in Q2 2021, closing 579 positions and reducing 430 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $36.3M.

  • Prelude Capital Management's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 3,700,000 shares worth $36.3M.
  • Prelude Capital Management added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $19.4M increase.
  • Prelude Capital Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $7.72M.
  • Prelude Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2021, selling an estimated $39.4M.
  • Prelude Capital Management's ten largest holdings make up 31% of its $3.36B portfolio in Q2 2021.
  • Prelude Capital Management opened 694 new positions and closed 579 in Q2 2021.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $3.36B.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.